CanSense
Developer of blood test to detect early-stage bowel cancer
CanSense has raised €1.7M across 1 funding round from 3 investors, most recently a round in Mar 2023. Based in Swansea, UK; active in Healthtech. Data as of 28 Oct 2026.
Swansea, UKcansenseltd.com ↗
Total raised
€1.7M
€1,683,993
Funding rounds
1
Investors
3
distinct backers
Active since
2023-03
latest 2023-03
Funding by year
EUR raised per yearCanSense — funding by year — interactive chart.
Data table
| CanSense — funding by year | |
|---|---|
| 2023 | €1.7M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-08 | Other | €1.7M | Development Bank of Wales,Mercia Ventures,Nonacus | View deal → |
Related news
- CanSense Raises £1.5M in Fundingfinsmes.com · 2023-03
Similar companies
same sector or countryGlobal coverage: FundingData